Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer

Condition:   Rectal Cancer Intervention:   Drug: Durvalumab (MEDI4736) Sponsors:   Grupo Espanol Multidisciplinario del Cancer Digestivo;   AstraZeneca;   Vall d'Hebron Institute of Oncology (VHIO) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials